4700 results
-
List item
Withdrawn application: Pioglitazone ratiopharm
pioglitazone, date of withdrawal: 03/02/2012, Initial authorisation, Last updated: 30/04/2012Pioglitazone ratiopharm: Withdrawn application … Pioglitazone ratiopharm: Withdrawal of the marketing … authorisation) Pioglitazone ratiopharm pioglitazone On 21 July … -
List item
Withdrawn application: Pioglitazone ratiopharm GmbH
pioglitazone, date of withdrawal: 03/02/2012, Initial authorisation, Last updated: 30/04/2012Pioglitazone ratiopharm GmbH: Withdrawn application … Pioglitazone ratiopharm GmbH: Withdrawal of the marketing … authorisation) Pioglitazone ratiopharm GmbH pioglitazone On 21 … -
List item
Human medicine European public assessment report (EPAR): Leflunomide ratiopharm
leflunomide, Arthritis, Rheumatoid
Date of authorisation: 28/11/2010,
, Revision: 16, Authorised, Last updated: 17/05/2022
Leflunomide ratiopharm Musculoskeletal Diseases Joint … Leflunomide ratiopharm … the public Leflunomide ratiopharm leflunomide This is a … -
List item
Human medicine European public assessment report (EPAR): Filgrastim ratiopharm
filgrastim, Neutropenia; Hematopoietic Stem Cell Transplantation; Cancer
Date of authorisation: 15/09/2008,
, Revision: 1, Withdrawn, Last updated: 20/07/2011
Filgrastim ratiopharm Neutropenia Hematopoietic … Filgrastim ratiopharm … Filgrastim ratiopharm, INN-filgrastim 7 Westferry … -
List item
Human medicine European public assessment report (EPAR): Rasagiline ratiopharm
rasagiline, Parkinson Disease
Date of authorisation: 12/01/2015, Revision: 8, Authorised, Last updated: 05/11/2021Rasagiline ratiopharm Nervous System Diseases Central … Rasagiline ratiopharm … for the public Rasagiline ratiopharm rasagiline This is a summary … -
List item
Human medicine European public assessment report (EPAR): Sildenafil ratiopharm
sildenafil, Erectile Dysfunction
Date of authorisation: 23/12/2009,, Revision: 19, Authorised, Last updated: 24/06/2022
Sildenafil ratiopharm Male Urogenital Diseases Genital … sildenafil. What is Sildenafil ratiopharm? Sildenafil ratiopharm is a medicine that contains … 50 and 100 mg). Sildenafil ratiopharm is a ‘ A generic medicine … -
List item
Human medicine European public assessment report (EPAR): Levetiracetam ratiopharm
levetiracetam, Epilepsy
Date of authorisation: 26/08/2011,, Revision: 14, Authorised, Last updated: 10/06/2022
Levetiracetam ratiopharm Nervous System Diseases Central … EPAR) for Levetiracetam ratiopharm. It explains how the Committee … of use for Levetiracetam ratiopharm. What is Levetiracetam ratiopharm and what is it used for … -
List item
Human medicine European public assessment report (EPAR): Desloratadine ratiopharm
desloratadine, Rhinitis, Allergic, Perennial; Urticaria; Rhinitis, Allergic, Seasonal
Date of authorisation: 13/01/2012,, Revision: 12, Authorised, Last updated: 24/06/2022
Desloratadine ratiopharm Respiratory Tract Diseases Nose … desloratadine Overview Desloratadine ratiopharm is a medicine used in adults … is unknown. Desloratadine ratiopharm contains the active substance … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm
clopidogrel, Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 23/09/2009,, Revision: 5, Withdrawn, Last updated: 12/12/2013
Clopidogrel ratiopharm Peripheral Vascular Diseases Stroke Myocardial … authorisation for Clopidogrel ratiopharm has been withdrawn at the … Summary documents Clopidogrel ratiopharm : EPAR - Summary for the … -
List item
Human medicine European public assessment report (EPAR): Memantine ratiopharm
memantine hydrochloride, Alzheimer Disease
Date of authorisation: 12/06/2013,, Revision: 8, Authorised, Last updated: 30/06/2022
Memantine ratiopharm Nervous System Diseases Central … report (EPAR) for Memantine ratiopharm. It explains how the European … advice on how to use Memantine ratiopharm. For practical information … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm GmbH
clopidogrel, Peripheral Vascular Diseases; Acute Coronary Syndrome; Myocardial Infarction; Stroke
Date of authorisation: 28/07/2009,, Revision: 12, Withdrawn, Last updated: 25/01/2021
Clopidogrel ratiopharm GmbH Peripheral Vascular … authorisation for Clopidogrel Ratiopharm GmbH has been withdrawn at … Summary documents Clopidogrel ratiopharm GmbH : EPAR - Summary for … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm
clopidogrel (as hydrogen sulfate), Myocardial Infarction; Acute Coronary Syndrome; Peripheral Vascular Diseases; Stroke
Date of authorisation: 18/02/2015,, Revision: 14, Authorised, Last updated: 15/11/2022
Clopidogrel ratiopharm Cardiovascular Diseases Vascular … report (EPAR) for Clopidogrel ratiopharm. It explains how the Agency … on how to use Clopidogrel ratiopharm. For practical information … -
List item
News: Update on investigation by Italian authorities into the supply of stolen medicines
Last updated: 03/06/2014Update on investigation by Italian authorities into the supply … authorities in Italy and Germany: Italian medicines agency (AIFA) Paul … announced investigation by Italian authorities into the supply … -
List item
Referral: Trimetadizine ratiopharm
trimetazidine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 22/01/2009, EC decision date: 19/03/2009, Last updated: 22/01/2009Trimetadizine ratiopharm … not known. Trimetazidine Ratiopharm is a generic medicine based … Trimetadizine-ratiopharm reviewed? ratiopharm GmbH submitted Trimetazidine-ratiopharm … -
List item
Referral: Valproat Ratiopharm Chrono
valproic acid, valproate, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 25/05/2010, EC decision date: 26/05/2010, Last updated: 23/07/2012Valproat Ratiopharm Chrono … company that markets Valproat Ratiopharm Chrono, a generic medicine … medicines, including Valproat Ratiopharm Chrono. Because bipolar disorder … -
List item
Referral: Fentanyl-ratiopharm Matrixpflaster
fentanyl, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/07/2007, EC decision date: 23/10/2007, Last updated: 14/12/2007only with opioid analgesics. Ratiopharm GmbH submitted applications … with opioid analgesics. Ratiopharm GmbH submitted applications … favourable for Fentanyl- ratiopharm 25/50/75/100 µg/h Matrixpflaster … -
List item
Referral: Fentanyl-ratiopharm_TTS
fentanyl, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/07/2007, EC decision date: 23/10/2007, Last updated: 14/12/2007only with opioid analgesics. Ratiopharm GmbH submitted applications … with opioid analgesics. Ratiopharm GmbH submitted applications … favourable for Fentanyl- ratiopharm 25/50/75/100 µg/h TTS and … -
List item
Referral: Lansoprazol-ratiopharm 15 mg and 30 mg
Lansoprazole, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 15/09/2005, EC decision date: 21/02/2006, Last updated: 25/02/2006was previously granted to ratiopharm GmbH in Finland on 7 November … was previously granted to ratiopharm GmbH in Finland on 7 November … administration Lansoprazol "ratiopharm" 15 mg Kapseln 15 mg Gastro-resistant … -
List item
Human medicine European public assessment report (EPAR): Ratiograstim
filgrastim, Neutropenia; Hematopoietic Stem Cell Transplantation; Cancer
Date of authorisation: 15/09/2008,, Revision: 15, Authorised, Last updated: 23/01/2023
the EU for Ratiograstim to ratiopharm GmbH on 15 September 2008 … -
List item
Human medicine European public assessment report (EPAR): Pazenir
paclitaxel, Breast Neoplasms
Date of authorisation: 06/05/2019,, Revision: 7, Authorised, Last updated: 15/03/2022
-
List item
Human medicine European public assessment report (EPAR): Eporatio
epoetin theta, Kidney Failure, Chronic; Anemia; Cancer
Date of authorisation: 29/10/2009, Revision: 12, Authorised, Last updated: 11/01/2022European Union for Eporatio to ratiopharm GmbH on 29 October 2009 … European Union for Eporatio to ratiopharm GmbH on 29 October 2009 … -
List item
National expert: Constanze Freiler, Austrian Medicines and Medical Devices Agency (updated)
- Declaration of interests - 80.3 KB | PDF
- Curriculum Vitae - 17.86 KB | PDF
Manager Pharmacovigilance TEVA ratiopharm, Vienna (Austria) Head of … Indication 04/2013-08/2018 TEVA ratiopharm Cross product responsibility … -
List item
Human medicine European public assessment report (EPAR): Glidipion (previously Pioglitazone Actavis Group)
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 15/03/2012,, Revision: 8, Withdrawn, Last updated: 17/10/2022
PDF/767.3 KB) (PDF/767.3 KB) Italian (PDF/700.65 KB) (PDF/700.65 … -
List item
Human medicine European public assessment report (EPAR): Pioglitazone Teva Pharma
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 26/03/2012,, Revision: 13, Withdrawn, Last updated: 30/08/2022
PDF/766.16 KB) (PDF/766.16 KB) Italian (PDF/696.38 KB) (PDF/696.38 … -
List item
Human medicine European public assessment report (EPAR): Paxlovid (updated)
nirmatrelvir, ritonavir, COVID-19 virus infection
Date of authorisation: 28/01/2022, Revision: 10, Authorised, Last updated: 07/03/2023PDF/168.67 KB) (PDF/168.67 KB) Italian (PDF/144.43 KB) (PDF/144.43 …